In NMRI mice bearing orthotopic MAC 15 colon tumors, a single intraperitoneal dose of 100 mg kg−1 disodium phosphate produced 97.34 ± 9.99% necrotic area at 24 h, versus 4.21 ± 6.74% in controls (mean ± s.d.; P < 0.001). Viable peripheral tumor remained, and avascular pulmonary deposits in prodrug-treated mice showed no necrosis. [1]
In male Sprague Dawley rats, a single intravenous 120 mg/kg dose of CA4DP caused myocardial injury and reduced stroke and cardiac indices at 72 h. Oral tadalafil pretreatment (5 mg/kg, 2 h earlier) attenuated cardiac injury, but lesions persisted and the stroke-index difference versus CA4DP alone was not significant. This high-dose toxicology result limits general claims of tolerability. [2]
Orthotopic tumor necrosis and an avascular-site limitation
Animal study · NMRI mice, 6–8 weeks; orthotopic MAC 15 colon adenocarcinoma and associated pulmonary deposits [1]
At 24 h after a single 100 mg kg−1 intraperitoneal dose, orthotopic tumors had extensive necrosis versus controls. A viable peripheral rim remained, and avascular lung deposits were unaffected. These observations support a vascularly dependent antitumor effect rather than complete tumor eradication.
- Disodium phosphate-treated orthotopic tumors
- Model: NMRI mice bearing orthotopic MAC 15 colon tumors; three treated mice stated
- Route: Intraperitoneal
- Frequency: Single dose
- Treatment course: 24-h histological endpoint
- Vehicle: Saline
- Reported limits: Control group size is not specified for Table 3; sex is not specified in Animals.
- Orthotopic tumor controls
- Model: NMRI mice bearing orthotopic MAC 15 colon tumors
- Treatment course: 24-h comparison
- Reported limits: Table 3 does not state control group size or explicit control injection details. Saline is the prodrug formulation, but a saline injection is not imputed to this arm.
Methods and source locations
Compound reported in the paper: Combretastatin A-4 disodium phosphate; Compound label in the paper: CA4P
Applies to the reported disodium phosphate material and model; does not validate an Adooq lot or equate the phosphate prodrug with parent CA4.
p.1319, Compounds and Histological assessment; p.1321 Table 3; pp.1322–1323 Orthotopic model studies (including lung deposits)
Necrotic area of orthotopic MAC 15 tumors at 24 h: Image analysis of histological sections; treated n=3 in Results; endpoint-specific statistical test not assigned (shared methods list Mann–Whitney U or Student’s t-test) — p.1321 Table 3; pp.1319–1320 Histological assessment and Statistical analysis; p.1322 Orthotopic model studies
Necrosis in avascular pulmonary tumor deposits after prodrug treatment: Microscopic examination; pulmonary deposits characterized as avascular in the same orthotopic model — pp.1322–1323 Orthotopic model studies; Fig.5 characterizes avascular lung deposits; Fig.6 illustrates parent CA4, not CA4P
Disodium phosphate-treated orthotopic tumors · p.1319, Compounds and Histological assessment; p.1321 Table 3; pp.1322–1323 Orthotopic model studies (including lung deposits)
Orthotopic tumor controls · p.1319, Compounds and Histological assessment; p.1321 Table 3; pp.1322–1323 Orthotopic model studies (including lung deposits)
Acute cardiac injury and incomplete protection by tadalafil
Animal study · Six-week-old male Sprague Dawley rats (Crl:CD(SD)); vehicle n=5, tadalafil n=5, CA4DP n=4, CA4DP+tadalafil n=4 [2]
At a deliberately cardiotoxic dose, CA4DP reduced cardiac function and caused myocardial lesions at 72 h. Tadalafil pretreatment attenuated injury but did not eliminate histological lesions or significantly improve stroke index relative to CA4DP alone.
- Vehicle
- Model: Six-week-old male Sprague Dawley rats (Crl:CD(SD)); vehicle n=5, tadalafil n=5, CA4DP n=4, CA4DP+tadalafil n=4
- Route: Oral vehicle, followed 2 h later by intravenous saline
- Frequency: Single administrations
- Treatment course: 72 h after saline for cardiac endpoints
- Vehicle: 0.5% methylcellulose orally; saline intravenously
- CA4DP alone
- Model: Six-week-old male Sprague Dawley rats (Crl:CD(SD)); vehicle n=5, tadalafil n=5, CA4DP n=4, CA4DP+tadalafil n=4
- Route: Intravenous bolus via caudal vein, 2 h after oral vehicle
- Frequency: Single CA4DP dose
- Treatment course: 72 h after CA4DP
- Vehicle: Saline; oral pretreatment with 0.5% methylcellulose
- Tadalafil alone
- Model: Six-week-old male Sprague Dawley rats (Crl:CD(SD)); vehicle n=5, tadalafil n=5, CA4DP n=4, CA4DP+tadalafil n=4
- Route: Oral tadalafil; intravenous saline 2 h later
- Frequency: Single administrations
- Treatment course: 72 h after intravenous saline
- Vehicle: Tadalafil in 0.5% methylcellulose; saline
- Tadalafil pretreatment plus CA4DP
- Model: Six-week-old male Sprague Dawley rats (Crl:CD(SD)); vehicle n=5, tadalafil n=5, CA4DP n=4, CA4DP+tadalafil n=4
- Route: Oral tadalafil then intravenous CA4DP bolus via caudal vein
- Frequency: Single dose of each drug
- Treatment course: 72 h after CA4DP
- Vehicle: Tadalafil in 0.5% methylcellulose; CA4DP in saline
Methods and source locations
Compound reported in the paper: Combretastatin A-4 disodium phosphate; Compound label in the paper: CA4DP
Applies to the reported disodium phosphate material and model; does not validate an Adooq lot or equate the phosphate prodrug with parent CA4.
Materials and Methods, introductory paragraph and Evaluation of cardiotoxicity using rats (sec3); Results, Evaluation of cardiotoxicity using rats (sec7); Fig.1B–C and Fig.2 with captions
Stroke Index and Cardiac Index at 72 h: Echocardiography under isoflurane; indices normalized to body surface area; Tukey’s test. Group sizes 5/5/4/4 for vehicle/tadalafil/CA4DP/combination. — sec3 and sec5; sec7; Fig.1B–C (printed p.154)
Myocardial lesions 72 h after CA4DP: H&E histology and Iba-1 immunostaining in the same cohort as echocardiography — sec3 and sec7; Fig.2A–F (printed p.155)
Vehicle · Materials and Methods, introductory paragraph and Evaluation of cardiotoxicity using rats (sec3); Results, Evaluation of cardiotoxicity using rats (sec7); Fig.1B–C and Fig.2 with captions
CA4DP alone · Materials and Methods, introductory paragraph and Evaluation of cardiotoxicity using rats (sec3); Results, Evaluation of cardiotoxicity using rats (sec7); Fig.1B–C and Fig.2 with captions
Tadalafil alone · Materials and Methods, introductory paragraph and Evaluation of cardiotoxicity using rats (sec3); Results, Evaluation of cardiotoxicity using rats (sec7); Fig.1B–C and Fig.2 with captions
Tadalafil pretreatment plus CA4DP · Materials and Methods, introductory paragraph and Evaluation of cardiotoxicity using rats (sec3); Results, Evaluation of cardiotoxicity using rats (sec7); Fig.1B–C and Fig.2 with captions